Author

Abdullah Al Jefri

Observed names: A. Al Jefri, Abdullah Al-Jefri

Institution: King Faisal Specialist Hospital & Research Centre

Observed institution: King Faisal Specialist Hospital & Research Centre

OpenAlex ID: A5072408243

Second Allogeneic Bone Marrow Transplantation after Myeloablative Conditioning Analysis of 43 Cases from Single Institution

2004 · A. Al Shanqeeti, P. Seth, et al. · Hematology · 26

Hematopoietic Stem Cell Transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: Report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group

2011 · Said Yousef Ahmed Mohamed, Ibtihal Fadhil, et al. · Hematology/Oncology and Stem Cell Therapy · 17

Cytomegalovirus infections in unrelated cord blood transplantation in pediatric patients: incidence, risk factors, and outcomes

2011 · Sami Al Hajjar, Amal Al Seraihi, et al. · Hematology/Oncology and Stem Cell Therapy · 13

Multicenter Validation of Spin-Density Projection-Assisted R2-MRI for the Non-Invasive Measurement of Liver Iron Concentration

2010 · Timothy G St Pierre, Amal El-Beshlawy, et al. · Blood · 5

Deferasirox (Exjade®) Treatment in Pediatric β-Thalassemia Patients with High Iron Burden: 2.8 Years Results from ESCALATOR Trial

2008 · Ali Taher, Abdullah Al Jefri, et al. · Blood · 3

Efficacy and Safety of Once-Daily Oral Deferasirox (Exjade®) during a Median of 2.7 Years of Treatment in Heavily Iron-Overloaded Patients with β-Thalassemia

2008 · Ali Taher, Amal El-Beshlawy, et al. · Blood · 3

Oral Deferasirox (Exjade®, ICL670) Is Effective, with a Clinically Manageable Safety Profile, in Pediatric β-Thalassemia Patients with High Iron Burden.

2007 · Ali Taher, Abdullah Al Jefri, et al. · Blood · 3

Noval Mutation in Four Saudi Families with Glanzmann Thrombasthenia

2011 · Tarek Owaidah, Hala Abalkhail, et al. · Blood · 2

Deferasirox (Exjade®, ICL670) Treatment of Inadequately Chelated β-Thalassemia Patients from the Middle East: The ESCALATOR Trial.

2005 · Ali Taher, Amal El-Beshlawy, et al. · Blood · 2

Deferasirox (Exjade®, ICL670) Is Effective and Tolerable in β-Thalassemia Patients with High Iron Burden and History of Inadequate Chelation Therapy.

2006 · A. Taher, A. El-Beshlawy, et al. · Blood · 1

Allogeneic Stem Cell Transplantation (sct) for Patients (pts) With Thalassemia Major: the Asian Experiences

2006 · Abdullah Al Jefri, Mohamad Fekredeen Ayas, et al. · 1

Pediatric Acute Myeloid Leukemia with KMT2A rearrangement -- can Partner Gene Help Determine Need for Hematopoietic Stem Cell Transplant?

2020 · Ibrahim Al Ghemlas, Saadiya Khan, et al.

Contents Vol. 123, 2010

2010 · Reinhold Munker, Chang-Gong Liu, et al. · Acta Haematologica

Author Index Vol. 123, 2010

2010 · Reinhold Munker, Chang-Gong Liu, et al. · Acta Haematologica

Danurubicin, cytosine arabinoside, etoposide, dexamethasone versus idarubicin, cytosine arabinoside, thioguanine in the treatment of childhood acute myeloid leukemia

1999 · Samira Rifai, M. M. Mustafa, et al.

Works count: 15

Citation count: 76

H-index: 4

I10-index: 3